To investigate the therapeutic potential of exon skipping as a future treatment option for EYS-associated RP, we adopted the CRISPR/Cas9 technology to generate a stable zebrafish line from which the genomic region encompassing eys exons 40-44 was specifically excised. Here, EYS is linked to retinitis pigmentosa 1.